PT  - JOURNAL ARTICLE
AU  - Jamal, Alainna J.
AU  - Mozafarihashjin, Mohammad
AU  - Coomes, Eric
AU  - Powis, Jeff
AU  - Liu, Angel Xin
AU  - Paterson, Aimee
AU  - Anceva-Sami, Sofia
AU  - Barati, Shiva
AU  - Crowl, Gloria
AU  - Faheem, Amna
AU  - Farooqi, Lubna
AU  - Khan, Saman
AU  - Prost, Karren
AU  - Poutanen, Susan
AU  - Yip, Lily
AU  - Zhong, Zoe
AU  - McGeer, Allison J.
AU  - Mubareka, Samira
AU  - ,
TI  - Sensitivity of nasopharyngeal swabs and saliva for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
AID  - 10.1101/2020.05.01.20081026
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.01.20081026
4099  - http://medrxiv.org/content/early/2020/05/05/2020.05.01.20081026.short
4100  - http://medrxiv.org/content/early/2020/05/05/2020.05.01.20081026.full
AB  - We enrolled 53 consecutive in-patients with COVID-19 at six hospitals in Toronto, Canada, and tested one nasopharyngeal swab/saliva sample pair from each patient for SARS-CoV-2. Overall, sensitivity was 89% for nasopharyngeal swabs and 77% for saliva (p=NS); difference in sensitivity was greatest for sample pairs collected later in illness.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Canadian Institutes of Health Research (Canadian 2019 Novel Coronavirus (COVID-19) Rapid Research Application #440359).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are with the authors.